10x Genomics, Inc. (LON:0A88)
London flag London · Delayed Price · Currency is GBP · Price in USD
8.13
-0.36 (-4.19%)
At close: May 23, 2025

10x Genomics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
377.06344.07359.28219.75587.45663.6
Upgrade
Short-Term Investments
49.8449.3429.41210.24--
Upgrade
Cash & Short-Term Investments
426.91393.4388.7429.98587.45663.6
Upgrade
Cash Growth
14.82%1.21%-9.60%-26.80%-11.48%56.45%
Upgrade
Receivables
52.5587.86114.83104.2185.2551.21
Upgrade
Inventory
74.7183.1173.7181.6359.9729.96
Upgrade
Prepaid Expenses
25.5720.0218.7916.5813.913.03
Upgrade
Restricted Cash
---2.631.0316.57
Upgrade
Total Current Assets
579.73584.39596.02635.04747.59774.37
Upgrade
Property, Plant & Equipment
301.66309.94344.93359.21230.41119.82
Upgrade
Goodwill
4.514.514.514.514.51-
Upgrade
Other Intangible Assets
15.1915.6716.6222.8625.422.35
Upgrade
Other Long-Term Assets
2.34.133.067.3710.9212.8
Upgrade
Total Assets
903.39918.64965.141,0291,019929.34
Upgrade
Accounts Payable
10.0712.9115.7421.617.354.71
Upgrade
Accrued Expenses
40.9152.0745.9851.953.2735.09
Upgrade
Current Portion of Leases
9.449.2911.529.045.135.94
Upgrade
Current Income Taxes Payable
4.784.945.054.084.628.65
Upgrade
Current Unearned Revenue
20.9520.6613.157.875.344.47
Upgrade
Other Current Liabilities
21.7517.7735.7336.4824.6459.27
Upgrade
Total Current Liabilities
107.9117.63127.16130.96110.36118.13
Upgrade
Long-Term Leases
70.6373.3383.8586.1476.8557.04
Upgrade
Long-Term Unearned Revenue
12.5712.518.813.17--
Upgrade
Other Long-Term Liabilities
5.45.034.282.9814.0515.1
Upgrade
Total Liabilities
196.5208.5224.1223.24201.26190.27
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
2,2092,1782,0261,8391,6811,544
Upgrade
Retained Earnings
-1,501-1,467-1,284-1,029-863.32-805.1
Upgrade
Comprehensive Income & Other
-0.37-0.49-0.43-4.340.02-0.05
Upgrade
Total Common Equity
706.9710.13741.04805.74817.57739.07
Upgrade
Shareholders' Equity
706.9710.13741.04805.74817.57739.07
Upgrade
Total Liabilities & Equity
903.39918.64965.141,0291,019929.34
Upgrade
Total Debt
80.0782.6195.3795.1881.9862.98
Upgrade
Net Cash (Debt)
346.83310.79293.33334.81505.47600.63
Upgrade
Net Cash Growth
24.03%5.95%-12.39%-33.76%-15.84%52.27%
Upgrade
Net Cash Per Share
2.862.582.502.944.585.94
Upgrade
Filing Date Shares Outstanding
123.13122.3119.17115.36112.84108.75
Upgrade
Total Common Shares Outstanding
123.13122.29119.1115.2112.51108.49
Upgrade
Working Capital
471.83466.75468.86504.08637.23656.24
Upgrade
Book Value Per Share
5.745.816.226.997.276.81
Upgrade
Tangible Book Value
687.19689.95719.92778.37787.66716.72
Upgrade
Tangible Book Value Per Share
5.585.646.046.767.006.61
Upgrade
Land
36.7736.7736.7736.7836.1-
Upgrade
Buildings
147.24147.09146.04---
Upgrade
Machinery
98.5597.0496.676.8762.6941.68
Upgrade
Construction In Progress
4.485.157.2515352.1919.59
Upgrade
Leasehold Improvements
90.1889.5796.4191.5267.5342.07
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.